Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature

Identification of associations between marketed drugs and adverse events from the biomedical literature assists drug safety monitoring efforts. Assessing the significance of such literature-derived associations and determining the granularity at which they should be captured remains a challenge.